Home › FTC sues AbbVie, Teva over testosterone replacement therapy deal
 

Keywords :   


FTC sues AbbVie, Teva over testosterone replacement therapy deal

2014-09-09 11:55:23| Biotech - Topix.net

The Federal Trade Commission filed a complaint Monday against AbbVie and Teva Pharmaceutical Industries alleging the companies illegally blocked American consumers' access to lower-cost versions of the testosterone replacement therapy AndroGel. According to the FTC complaint, AbbVie of Chicago and its partner Besins Healthcare Inc. allegedly filed baseless patent infringement lawsuits against potential generic competitors to delay the introduction of lower-priced versions of AndroGel, which generates more than $1 billion a year in annual sales.

Tags: deal therapy replacement sues

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 3
29.06Tropical Storm Beryl Public Advisory Number 3
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 3
29.06Tropical Storm Beryl Forecast Advisory Number 3
29.06Eastern North Pacific Tropical Weather Outlook
29.06Atlantic Tropical Weather Outlook
More »